open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

51. Biological concepts of breast cancer: implications for therapy

M. Tubiana, S. Koscielny
DOI: 10.1016/S1507-1367(01)70421-X
·
Rep Pract Oncol Radiother 2001;6(1):50.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

The data from over 3000 breast cancer patients treated without adjuvant chemotherapy and followed-up for over 15 years were studied with two aims:

  • 1)

    to analyze the relationship between tumor diameter and incidence of distant metastases during the 25 years after initial treatment. The threshold volume at which dissemination occurs can be estimated in each subset of patients and varies widely; it is inversely correlated with the histologic grade and the number of involved axillary nodes.

  • 2)

    to investigate the impact of a residual tumor on distant dissemination. In patients with local recurrence, the incidence of distant dissemination is elevated. The analysis of the delay between the initial treatment and clinical emergence of the metastases shows that the excess of metastases corresponds to disseminations which are initiated after initial treatment and therefore originated from the residual tumor.

This conclusion was supported by the update of s controlled clinical trial comparing two adjuvant treatments: A) a chemotherapy by CMF or B) post-operative radiotherapy (RT) followed by immunothcrapy with poly A – poly U. At 15 years the cumulative incidence of local recurrence and of distant metastases is significantly lower in the B group (42% metastasis-free survival in the RT group and 29% in the CT group p=0.03). This result seems to be due mostly to lower incidence of local recurrence.

Abstract

The data from over 3000 breast cancer patients treated without adjuvant chemotherapy and followed-up for over 15 years were studied with two aims:

  • 1)

    to analyze the relationship between tumor diameter and incidence of distant metastases during the 25 years after initial treatment. The threshold volume at which dissemination occurs can be estimated in each subset of patients and varies widely; it is inversely correlated with the histologic grade and the number of involved axillary nodes.

  • 2)

    to investigate the impact of a residual tumor on distant dissemination. In patients with local recurrence, the incidence of distant dissemination is elevated. The analysis of the delay between the initial treatment and clinical emergence of the metastases shows that the excess of metastases corresponds to disseminations which are initiated after initial treatment and therefore originated from the residual tumor.

This conclusion was supported by the update of s controlled clinical trial comparing two adjuvant treatments: A) a chemotherapy by CMF or B) post-operative radiotherapy (RT) followed by immunothcrapy with poly A – poly U. At 15 years the cumulative incidence of local recurrence and of distant metastases is significantly lower in the B group (42% metastasis-free survival in the RT group and 29% in the CT group p=0.03). This result seems to be due mostly to lower incidence of local recurrence.

Get Citation
About this article
Title

51. Biological concepts of breast cancer: implications for therapy

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

50

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70421-X

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):50.

Authors

M. Tubiana
S. Koscielny

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl